Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques

Clinical trial NCT05165537 · RECRUITING

Trial details

NCT number: NCT05165537
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Magnetic Resonance Spectroscopy

Start date: 2022-03-01
Primary completion: 2028-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.